lymphoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ?Malignant lymphoma was diagnosed according to the Chinese Society of Clinical Oncology (CSCO) Lymphoma Diagnosis and Treatment Guidelines (2022 edition); Be aware of their condition, diagnosis and treatment, and voluntarily participate in the study; Have indications of chemotherapy and still need to receive 3 or more cycles of chemotherapy (including targeted therapy or immunotherapy combined chemotherapy); ? Normal hearing, a certain ability to understand and express; ? Age = 18 years old.
Exclusion criteria
Exclusion criteria: ?Mental illness or cognitive impairment (patients were assessed using the Mini-Mental State Assessment Scale (MMSE)); ? With other tumors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional Assessment Cancer Therapy- Lymphoma;Exercise of Self-care Agency Scale;Unplanned readmission rate;Follow-up satisfaction;Compliance of lymphoma patients during treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital anxiety and depression scale;Physical status score;length of stay;Incidence of infection;Antibiotic use;Use of blood products; | — |
Countries
China
Contacts
The Second Affiliated Hospital of Fujian Medical University